Related Experiment Video
Updated: Jun 6, 2026

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
Published on: June 14, 2016
Cytokines and cardiac hypertrophy: roles of angiotensin II and basic fibroblast growth factor
D M Kaye1, R A Kelly, T W Smith
1Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.
Insights
Cardiac cells release growth factors like Angiotensin II in response to mechanical stress, driving cardiac hypertrophy. Understanding these molecular mechanisms is key to treating heart muscle growth.
Area of Science:
- Cardiovascular Biology
- Molecular Cardiology
- Cellular Signaling
Background:
- Hemodynamic factors causing cardiac hypertrophy are known, but cellular mechanisms remain unclear.
- Trophic factors released by heart cells may influence cardiac growth via autocrine/paracrine signaling.
- Cardiac myocytes are the primary cells involved in cardiac hypertrophy.
Purpose of the Study:
- To elucidate the cellular and molecular mechanisms translating mechanical stimuli into cardiac muscle growth.
- To identify specific trophic factors and signaling pathways involved in cardiac hypertrophy.
- To investigate the autocrine and paracrine roles of cytokines in cardiac response to mechanical load.
Main Methods:
- In vivo and in vitro studies examining hypertrophic actions of specific growth factors.
- Analysis of cytokine release by cardiac myocytes under mechanical load.
- Investigation of Angiotensin II signaling via the AT(1) receptor subtype.
Main Results:
- Angiotensin II (via AT(1) receptor), basic fibroblast growth factor, and heparin-binding epidermal growth factor promote cardiac hypertrophy.
- Cardiac myocytes release these cytokines in response to increased mechanical load.
- Autocrine and paracrine signaling pathways are implicated in cardiac growth.
Conclusions:
- Cardiac myocytes release key trophic factors, including Angiotensin II, in response to mechanical stress.
- These factors mediate cardiac hypertrophy through autocrine and paracrine mechanisms.
- Understanding these pathways is crucial for developing therapeutic strategies for cardiac hypertrophy.
Abstract:
1. While the haemodynamic influences that cause cardiac hypertrophy are well known, the cellular and molecular mechanisms by which a mechanical stimulus is translated into a growth response by cardiac muscle have remained uncertain. 2. Current evidence suggests that a number of trophic factors may be released by cellular constituents of the heart, acting in an autocrine or paracrine manner to influence the growth response and phenotype of neighbouring cells. 3. Angiotensin II, acting via the AT(1) receptor subtype, and both basic fibroblast growth factor and heparin-binding epidermal growth factor have been shown to exert hypertrophic actions in vivo and in vitro. Studies also indicate that cardiac myocytes themselves are capable of releasing all of these cytokines in response to increased mechanical load.
Related Concept Videos
Heart Failure II: Pathophysiology
Cellular Adaptation II: Hypertrophy
Pathophysiology of Heart Failure
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
